Venus Concept Inc (VERO) Inventory Turnover Ratio, from third quarter 2025 to third quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Venus Concept Inc   (NASDAQ: VERO)
 

Venus Concept Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Venus Concept Inc inventory turnover ratio, the Venus Concept Inc 's ability to sell and replace its inventory in the third quarter 2025, sequentially increased to 0.3 in the third quarter 2025, yet the ratio remained below the average, as VERO's market remain challenging.Average inventory processing period, for the Venus Concept Inc in Sep 30 2025 quarter, has decreased to 1217 days, compare to 1259 days, in the Jun 30 2025 quarter.

Within Healthcare sector 369 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. 1492.

VERO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Venus Concept Inc Market Share?

What is Inventory Turnover Ratio?




VERO Inventory Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Inventory Growth -16.59 % -19.83 % -15.95 % -23.89 % -19.19 %
Y / Y Cost of Sales Growth 0 % -50 % 0 % -19.74 % 0 %
Inventory Turnover Ratio (TTM) 0.3 0.29 0.32 0.31 0.31
VERO's Total Ranking # 1492 # 1492 # 1868 # 1868 # 1546
Average inventory processing period 1220 1277 1124 1174 1163
Seq. Inventory Growth -0.58 % -10.06 % 0.41 % -7.1 % -4.44 %
Seq. Cost of Sales Growth 0 % 0 % -50 % 100 % -50 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 162
Healthcare Sector # 370
Overall Market # 1492

Inventory Turnover Ratio Statistics
High Average Low
4.71 1.59 0.17
(Mar 31 2018)   (Sep 30 2017)




Financial Statements
Venus Concept Inc 's Inventories $ 16 Millions Visit VERO's Balance sheet
Venus Concept Inc 's Cost of Revenues TTM $ 5 Millions Visit VERO's Income Statement
What are VERO's Sales? Visit VERO's Sales by Segment

Other Inventory Turnover Ratios
Venus Concept Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VERO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VERO's Competitors
Inventory Turnover Ratio for VERO's Suppliers
Inventory Turnover Ratio for VERO's Customers

You may also want to know
VERO's Sales Growth Rates VERO's Pe Price to earnings ratio VERO's Receivables Turnover Ratio VERO's Stock Quote
VERO's Net Income Growth Rates VERO's Ps Price to Sales ratio VERO's Sales per Employee VERO's Asset Turnover Ratio
VERO's Net Margin VERO's Pb Price to Book ratio VERO's Financial Strength Ratios VERO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Petvivo Holdings Inc   0.87 $ 0.396  Millions$ 0  Millions
Cormedix Inc   0.86 $ 11.291  Millions$ 13  Millions
Siga Technologies Inc  0.85 $ 40.846  Millions$ 48  Millions
Maxcyte inc   0.84 $ 6.893  Millions$ 8  Millions
Adagio Medical Holdings inc   0.81 $ 1.679  Millions$ 2  Millions
Ionis Pharmaceuticals Inc   0.80 $ 12.215  Millions$ 15  Millions
Profound Medical Corp   0.79 $ 3.933  Millions$ 5  Millions
Verrica Pharmaceuticals Inc   0.78 $ 1.900  Millions$ 2  Millions
Cvrx inc   0.77 $ 9.000  Millions$ 12  Millions
Dynavax Technologies Corporation  0.76 $ 55.617  Millions$ 73  Millions
Butterfly Network Inc   0.74 $ 50.000  Millions$ 68  Millions
Neurocrine Biosciences Inc   0.72 $ 43.800  Millions$ 61  Millions
Xeris Biopharma Holdings Inc   0.70 $ 41.100  Millions$ 59  Millions
Establishment Labs Holdings Inc   0.68 $ 60.000  Millions$ 88  Millions
Liquidia Corporation  0.66 $ 5.371  Millions$ 8  Millions
Anika Therapeutics Inc   0.62 $ 12.145  Millions$ 20  Millions
Clene Inc   0.62 $ 0.038  Millions$ 0  Millions
Heron Therapeutics Inc   0.62 $ 39.000  Millions$ 63  Millions
Gyre Therapeutics Inc   0.61 $ 4.850  Millions$ 8  Millions
Milestone Scientific Inc   0.58 $ 2.317  Millions$ 4  Millions
Tg Therapeutics Inc   0.55 $ 77.972  Millions$ 143  Millions
Orthopediatrics Corp  0.52 $ 64.000  Millions$ 123  Millions
Envoy Medical Inc   0.50 $ 0.820  Millions$ 2  Millions
Igc Pharma Inc   0.49 $ 0.595  Millions$ 1  Millions
Immunocore Holdings Plc  0.46 $ 2.714  Millions$ 6  Millions
Biomarin Pharmaceutical Inc  0.44 $ 577.872  Millions$ 1,307  Millions
Solana Company  0.43 $ 0.474  Millions$ 1  Millions
Amicus Therapeutics inc   0.41 $ 60.000  Millions$ 146  Millions
Vystar Corporation  0.40 $ 0.027  Millions$ 0  Millions
Outlook Therapeutics Inc   0.38 $ 1.356  Millions$ 4  Millions

Date modified: 2026-09-12T06:22:54+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.